1	The	The	B-NP	DT	O	2	NMOD
2	role	role	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	routine	routine	B-NP	JJ	O	5	NMOD
5	immunohistochemistry	immunohistochemistry	I-NP	NN	O	3	PMOD
6	for	for	B-PP	IN	O	2	NMOD
7	Helicobacter	Helicobacter	B-NP	NN	O	8	NMOD
8	pylori	pylori	I-NP	NN	O	6	PMOD
9	in	in	B-PP	IN	O	2	NMOD
10	gastric	gastric	B-NP	JJ	O	11	NMOD
11	biopsy	biopsy	I-NP	NN	O	9	PMOD
12	.	.	O	.	O	2	P

1	Helicobacter	Helicobacter	B-NP	NN	O	3	NMOD
2	pylori	pylori	I-NP	NN	O	3	NMOD
3	infection	infection	I-NP	NN	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	associated	associate	I-VP	VBN	O	4	VC
6	with	with	B-PP	IN	O	5	VMOD
7	gastritis	gastritis	B-NP	NN	O	20	NMOD
8	,	,	O	,	O	20	P
9	gastric	gastric	B-NP	JJ	O	10	NMOD
10	ulcer	ulcer	I-NP	NN	O	20	NMOD
11	,	,	O	,	O	20	P
12	gastric	gastric	B-NP	JJ	O	13	NMOD
13	adenocarcinoma	adenocarcinoma	I-NP	NN	O	20	NMOD
14	,	,	O	,	O	20	P
15	and	and	O	CC	O	20	NMOD
16	mucosal	mucosal	B-NP	JJ	O	20	NMOD
17	associated	associate	I-NP	VBN	O	20	NMOD
18	lymphoid	lymphoid	I-NP	JJ	O	20	NMOD
19	tissue	tissue	I-NP	NN	O	20	NMOD
20	lymphoma	lymphoma	I-NP	NN	O	6	PMOD
21	.	.	O	.	O	4	P

1	Documenting	Document	B-VP	VBG	O	11	SUB
2	the	the	B-NP	DT	O	3	NMOD
3	presence	presence	I-NP	NN	O	1	OBJ
4	of	of	B-PP	IN	O	3	NMOD
5	H	H	B-NP	NN	O	6	NMOD
6	pylori	pylori	I-NP	NN	O	4	PMOD
7	in	in	B-PP	IN	O	1	NMOD
8	a	a	B-NP	DT	O	10	NMOD
9	gastric	gastric	I-NP	JJ	O	10	NMOD
10	biopsy	biopsy	I-NP	NN	O	7	PMOD
11	is	be	B-VP	VBZ	O	0	ROOT
12	essential	essential	B-ADJP	JJ	O	11	PRD
13	for	for	B-PP	IN	O	12	AMOD
14	appropriate	appropriate	B-NP	JJ	O	16	NMOD
15	patient	patient	I-NP	NN	O	16	NMOD
16	care	care	I-NP	NN	O	13	PMOD
17	.	.	O	.	O	11	P

1	Several	Several	B-NP	JJ	O	3	NMOD
2	special	special	I-NP	JJ	O	3	NMOD
3	stains	stain	I-NP	NNS	O	9	NMOD
4	and	and	O	CC	O	5	NMOD
5	immunohistochemistry	immunohistochemistry	B-NP	NN	O	9	NMOD
6	(	(	O	(	O	8	DEP
7	IHC	IHC	B-NP	NN	O	8	DEP
8	)	)	O	)	O	5	NMOD
9	stain	stain	B-NP	NN	O	13	SUB
10	for	for	B-PP	IN	O	9	NMOD
11	H	H	B-NP	NN	O	12	NMOD
12	pylori	pylori	I-NP	NN	O	10	PMOD
13	are	be	B-VP	VBP	O	19	VMOD
14	available	available	B-ADJP	JJ	O	13	PRD
15	,	,	O	,	O	19	P
16	and	and	O	CC	O	19	VMOD
17	many	many	B-NP	JJ	O	18	NMOD
18	laboratories	laboratory	I-NP	NNS	O	19	SUB
19	are	be	B-VP	VBP	O	0	ROOT
20	routinely	routinely	I-VP	RB	O	19	VMOD
21	using	use	I-VP	VBG	O	19	VMOD
22	one	one	B-NP	CD	O	21	OBJ
23	of	of	B-PP	IN	O	22	NMOD
24	them	them	B-NP	PRP	O	23	PMOD
25	.	.	O	.	O	19	P

1	We	We	B-NP	PRP	O	2	SUB
2	introduced	introduce	B-VP	VBD	O	16	VMOD
3	routine	routine	B-NP	JJ	O	4	NMOD
4	IHC	IHC	I-NP	NN	O	2	OBJ
5	for	for	B-PP	IN	O	4	NMOD
6	H	H	B-NP	NN	O	7	NMOD
7	pylori	pylori	I-NP	NN	O	5	PMOD
8	about	about	B-PP	IN	O	2	VMOD
9	a	a	B-NP	DT	O	10	NMOD
10	year	year	I-NP	NN	O	8	PMOD
11	ago	ago	B-ADVP	RB	O	10	NMOD
12	,	,	O	,	O	16	P
13	and	and	O	CC	O	16	VMOD
14	this	this	B-NP	DT	O	15	NMOD
15	study	study	I-NP	NN	O	16	SUB
16	aims	aim	B-VP	VBZ	O	0	ROOT
17	to	to	I-VP	TO	O	18	VMOD
18	investigate	investigate	I-VP	VB	O	16	VMOD
19	the	the	B-NP	DT	O	20	NMOD
20	value	value	I-NP	NN	O	18	OBJ
21	of	of	B-PP	IN	O	20	NMOD
22	this	this	B-NP	DT	O	23	NMOD
23	protocol	protocol	I-NP	NN	O	21	PMOD
24	.	.	O	.	O	16	P

1	A	A	B-NP	DT	O	2	NMOD
2	total	total	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	224	224	B-NP	CD	O	5	NMOD
5	patients	patient	I-NP	NNS	O	3	PMOD
6	qualified	qualify	B-VP	VBN	O	5	NMOD
7	for	for	B-PP	IN	O	6	VMOD
8	the	the	B-NP	DT	O	10	NMOD
9	study	study	I-NP	NN	O	10	NMOD
10	criteria	criterion	I-NP	NNS	O	7	PMOD
11	during	during	B-PP	IN	O	2	NMOD
12	this	this	B-NP	DT	O	13	NMOD
13	period	period	I-NP	NN	O	11	PMOD
14	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	diagnoses	diagnosis	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	chronic	chronic	B-NP	JJ	O	6	NMOD
5	active	active	I-NP	JJ	O	6	NMOD
6	gastritis	gastritis	I-NP	NN	O	31	NMOD
7	(	(	O	(	O	9	DEP
8	68	68	B-NP	CD	O	9	DEP
9	)	)	O	)	O	6	NMOD
10	,	,	O	,	O	31	P
11	chronic	chronic	B-NP	JJ	O	12	NMOD
12	gastritis	gastritis	I-NP	NN	O	31	NMOD
13	(	(	O	(	O	15	DEP
14	76	76	B-NP	CD	O	15	DEP
15	)	)	O	)	O	12	NMOD
16	,	,	O	,	O	31	P
17	no	no	B-NP	DT	O	19	NMOD
18	pathologic	pathologic	I-NP	JJ	O	19	NMOD
19	abnormality	abnormality	I-NP	NN	O	31	NMOD
20	(	(	O	(	O	22	DEP
21	50	50	B-NP	CD	O	22	DEP
22	)	)	O	)	O	19	NMOD
23	,	,	O	,	O	31	P
24	reactive	reactive	B-NP	JJ	O	25	NMOD
25	gastropathy	gastropathy	I-NP	NN	O	31	NMOD
26	(	(	O	(	O	28	DEP
27	24	24	B-NP	CD	O	28	DEP
28	)	)	O	)	O	25	NMOD
29	,	,	O	,	O	31	P
30	and	and	O	CC	O	31	NMOD
31	polyps	polyp	B-NP	NNS	O	3	PRD
32	(	(	O	(	O	34	DEP
33	6	6	B-NP	CD	O	34	DEP
34	)	)	O	)	O	31	NMOD
35	.	.	O	.	O	3	P

1	Fifty-four	Fifty-four	B-NP	CD	O	2	NMOD
2	cases	case	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	positive	positive	B-ADJP	JJ	O	3	PRD
5	for	for	B-PP	IN	O	4	AMOD
6	H	H	B-NP	NN	O	7	NMOD
7	pylori	pylori	I-NP	NN	O	5	PMOD
8	on	on	B-PP	IN	O	7	NMOD
9	IHC	IHC	B-NP	NN	B-protein	8	PMOD
10	,	,	O	,	O	9	P
11	including	include	B-PP	VBG	O	9	NMOD
12	50	50	B-NP	CD	O	15	NMOD
13	chronic	chronic	I-NP	JJ	O	15	NMOD
14	active	active	I-NP	JJ	O	15	NMOD
15	gastritis	gastritis	I-NP	NN	O	19	NMOD
16	and	and	O	CC	O	19	NMOD
17	4	4	B-NP	CD	O	19	NMOD
18	chronic	chronic	I-NP	JJ	O	19	NMOD
19	gastritis	gastritis	I-NP	NN	O	11	PMOD
20	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	4	NMOD
2	IHC	IHC	I-NP	NN	O	4	NMOD
3	positive	positive	I-NP	JJ	O	4	NMOD
4	rate	rate	I-NP	NN	O	5	SUB
5	was	be	B-VP	VBD	O	0	ROOT
6	73.5	73.5	B-NP	CD	O	7	NMOD
7	%	%	I-NP	NN	O	27	NMOD
8	(	(	O	(	O	10	DEP
9	50/68	50/68	B-NP	CD	O	10	DEP
10	)	)	O	)	O	7	NMOD
11	in	in	B-PP	IN	O	7	NMOD
12	chronic	chronic	B-NP	JJ	O	14	NMOD
13	active	active	I-NP	JJ	O	14	NMOD
14	gastritis	gastritis	I-NP	NN	O	11	PMOD
15	,	,	O	,	O	27	P
16	5.3	5.3	B-NP	CD	O	17	NMOD
17	%	%	I-NP	NN	O	27	NMOD
18	(	(	O	(	O	20	DEP
19	4/76	4/76	B-NP	CD	O	20	DEP
20	)	)	O	)	O	17	NMOD
21	in	in	B-PP	IN	O	17	NMOD
22	chronic	chronic	B-NP	JJ	O	23	NMOD
23	gastritis	gastritis	I-NP	NN	O	21	PMOD
24	,	,	O	,	O	27	P
25	and	and	O	CC	O	27	NMOD
26	0	0	B-NP	CD	O	27	NMOD
27	%	%	I-NP	NN	O	5	PRD
28	(	(	O	(	O	30	DEP
29	0/80	0/80	B-NP	CD	O	30	DEP
30	)	)	O	)	O	27	NMOD
31	in	in	B-PP	IN	O	27	NMOD
32	other	other	B-NP	JJ	O	33	NMOD
33	diagnoses	diagnosis	I-NP	NNS	O	31	PMOD
34	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	2	NMOD
2	sensitivity/specificity	sensitivity/specificity	I-NP	NN	O	14	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	finding	find	B-VP	VBG	O	3	PMOD
5	H	H	B-NP	NN	O	6	NMOD
6	pylori	pylori	I-NP	NN	O	4	OBJ
7	by	by	B-PP	IN	O	4	VMOD
8	blindly	blindly	B-VP	RB	O	9	VMOD
9	reviewing	review	I-VP	VBG	O	7	PMOD
10	hematoxylin	hematoxylin	B-NP	NN	B-protein	13	NMOD
11	and	and	I-NP	CC	O	13	NMOD
12	eosin	eosin	I-NP	NN	O	13	NMOD
13	slides	slide	I-NP	NNS	O	9	OBJ
14	was	be	B-VP	VBD	O	0	ROOT
15	100	100	B-NP	CD	O	16	AMOD
16	%	%	I-NP	NN	O	18	NMOD
17	/100	/100	B-NP	CD	O	18	NMOD
18	%	%	I-NP	NN	O	21	NMOD
19	,	,	O	,	O	21	P
20	100	100	B-NP	CD	O	21	AMOD
21	%	%	I-NP	NN	O	23	NMOD
22	/100	/100	B-NP	CD	O	23	NMOD
23	%	%	I-NP	NN	O	34	NMOD
24	,	,	O	,	O	34	P
25	95	95	B-NP	CD	O	28	NMOD
26	%	%	I-NP	NN	O	28	NMOD
27	/100	/100	B-NP	CD	O	28	NMOD
28	%	%	I-NP	NN	O	34	NMOD
29	,	,	O	,	O	34	P
30	and	and	O	CC	O	34	NMOD
31	100	100	B-NP	CD	O	32	AMOD
32	%	%	I-NP	NN	O	34	NMOD
33	/100	/100	B-NP	CD	O	34	NMOD
34	%	%	I-NP	NN	O	14	PRD
35	from	from	B-PP	IN	O	34	NMOD
36	the	the	B-NP	DT	O	38	NMOD
37	4	4	I-NP	CD	O	38	NMOD
38	authors	author	I-NP	NNS	O	35	PMOD
39	.	.	O	.	O	14	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	showed	show	B-VP	VBD	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	many	many	B-NP	JJ	O	7	NMOD
6	gastric	gastric	I-NP	JJ	O	7	NMOD
7	biopsies	biopsy	I-NP	NNS	O	14	SUB
8	(	(	O	(	O	13	DEP
9	35.7	35.7	B-NP	CD	O	10	NMOD
10	%	%	I-NP	NN	O	12	NMOD
11	,	,	O	,	O	12	P
12	80/224	80/224	B-NP	CD	O	13	DEP
13	)	)	O	)	O	7	NMOD
14	had	have	B-VP	VBD	O	4	SBAR
15	no	no	B-NP	DT	O	17	NMOD
16	pathologic	pathologic	I-NP	JJ	O	17	NMOD
17	abnormality	abnormality	I-NP	NN	O	20	NMOD
18	or	or	O	CC	O	20	NMOD
19	reactive	reactive	B-NP	JJ	O	20	NMOD
20	gastropathy	gastropathy	I-NP	NN	O	14	OBJ
21	and	and	O	CC	O	14	VMOD
22	did	do	B-VP	VBD	O	14	VMOD
23	not	not	I-VP	RB	O	22	VMOD
24	need	need	I-VP	VB	O	22	VC
25	a	a	B-NP	DT	O	27	NMOD
26	routine	routine	I-NP	JJ	O	27	NMOD
27	IHC	IHC	I-NP	NN	O	24	OBJ
28	for	for	B-PP	IN	O	27	NMOD
29	H	H	B-NP	NN	O	30	NMOD
30	pylori	pylori	I-NP	NN	O	28	PMOD
31	.	.	O	.	O	3	P

1	Hematoxylin	Hematoxylin	B-NP	NN	B-protein	5	NMOD
2	and	and	I-NP	CC	O	5	NMOD
3	eosin	eosin	I-NP	NN	O	5	NMOD
4	slide	slide	I-NP	NN	O	5	NMOD
5	review	review	I-NP	NN	O	6	SUB
6	had	have	B-VP	VBD	O	0	ROOT
7	a	a	B-NP	DT	O	10	NMOD
8	very	very	I-NP	RB	O	9	AMOD
9	good	good	I-NP	JJ	O	10	NMOD
10	sensitivity	sensitivity	I-NP	NN	O	12	NMOD
11	and	and	I-NP	CC	O	12	NMOD
12	specificity	specificity	I-NP	NN	O	6	OBJ
13	with	with	B-PP	IN	O	6	VMOD
14	all	all	B-NP	DT	O	15	NMOD
15	levels	level	I-NP	NNS	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	observers	observer	B-NP	NNS	O	16	PMOD
18	.	.	O	.	O	6	P

1	In	In	B-PP	IN	O	8	VMOD
2	summary	summary	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	8	P
4	IHC	IHC	B-NP	NN	B-protein	8	SUB
5	for	for	B-PP	IN	O	4	NMOD
6	H	H	B-NP	NN	O	7	NMOD
7	pylori	pylori	I-NP	NN	O	5	PMOD
8	should	should	B-VP	MD	O	0	ROOT
9	not	not	I-VP	RB	O	8	VMOD
10	be	be	I-VP	VB	O	8	VC
11	routinely	routinely	I-VP	RB	O	10	VMOD
12	used	use	I-VP	VBN	O	10	VC
13	,	,	O	,	O	12	P
14	especially	especially	B-ADVP	RB	O	12	VMOD
15	during	during	B-PP	IN	O	12	VMOD
16	these	these	B-NP	DT	O	19	NMOD
17	economically	economically	I-NP	RB	O	18	AMOD
18	challenging	challenging	I-NP	JJ	O	19	NMOD
19	times	time	I-NP	NNS	O	15	PMOD
20	.	.	O	.	O	8	P

1	Immunohistochemistry	Immunohistochemistry	B-NP	NN	O	2	SUB
2	should	should	B-VP	MD	O	0	ROOT
3	be	be	I-VP	VB	O	2	VC
4	reserved	reserve	I-VP	VBN	O	3	VC
5	for	for	B-PP	IN	O	4	VMOD
6	unexplained	unexplained	B-NP	JJ	O	7	NMOD
7	gastritis	gastritis	I-NP	NN	O	11	NMOD
8	and	and	O	CC	O	11	NMOD
9	previously	previously	B-NP	RB	O	10	AMOD
10	treated	treat	I-NP	VBN	O	11	NMOD
11	patients	patient	B-NP	NNS	O	5	PMOD
12	with	with	B-PP	IN	O	11	NMOD
13	likely	likely	B-NP	RB	O	14	AMOD
14	low	low	I-NP	JJ	O	16	NMOD
15	organism	organism	I-NP	NN	O	16	NMOD
16	density	density	I-NP	NN	O	12	PMOD
17	.	.	O	.	O	2	P

